vancomycin monitoring device
Pre-clinical- Indications
- Therapeutic drug monitoring
Company intelligence / Profile preview
ZiO Health has developed a proprietary, AI-driven, hand-held biosensor platform for point-of-care therapeutic drug monitoring. Their lead application is real-time vancomycin level testing to enable precision dosing, aiming to maximize efficacy and minimize toxicity. The device provides quantitative results at the bedside, reducing costs and hospital stays compared to traditional lab-based methods. Clinical validation data is not publicly detailed but the product is positioned as ready or near-ready for market deployment.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZiO Health.